SCHEMBL4903136

SCHEMBL4903136

Cc1ccc(C(=O)Nc2ccc(Nc3nccc(-c4cccnc4)n3)cc2)cc1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRA P16234 15/20 0.82
ABL1 P00519 13/20 0.82
BCR P11274 12/20 0.82
PDGFRB P09619 10/20 0.82
HDAC1 Q13547 1/20 0.69
PRKCA P17252 5/20 0.68
EGFR P00533 1/20 0.68
KIT P10721 4/20 0.67
SRC P12931 3/20 0.67
PRKCD Q05655 3/20 0.67
PRKD3 O94806 1/20 0.67
PRKCG P05129 1/20 0.67
PRKCB P05771 1/20 0.67
PRKCH P24723 1/20 0.67
PRKCI P41743 1/20 0.67
PRKCE Q02156 1/20 0.67
PRKCQ Q04759 1/20 0.67
PRKCZ Q05513 1/20 0.67
PRKD1 Q15139 1/20 0.67
ABL2 P42684 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9763 0.90 ABL1 (1.00) PDGFRAABL1BCRPDGFRBPRKCA
SCHEMBL4903275 0.90 ABL1 (0.81) PDGFRAABL1BCRPDGFRBHDAC1
SCHEMBL9820 0.89 PDGFRA (1.00) PDGFRAABL1BCRPDGFRBPRKCA
SCHEMBL4905733 0.89 PDGFRA (0.77) PDGFRAABL1BCRPDGFRBHDAC1
SCHEMBL4901659 0.89 ABL1 (0.81) PDGFRAABL1BCRPDGFRBHDAC1
SCHEMBL4897346 0.88 ABL1 (0.67) PDGFRAABL1BCRPDGFRBHDAC1
SCHEMBL7474316 0.86 HDAC1 (0.68) PDGFRAABL1BCRPDGFRBHDAC1
SCHEMBL4901694 0.86 ABL1 (0.83) PDGFRAABL1BCRPDGFRBHDAC1
SCHEMBL3863391 0.86 PDGFRA (0.78) PDGFRAABL1BCRPDGFRBHDAC1
SCHEMBL14021032 0.84 PDGFRA (0.62) PDGFRAABL1BCRPDGFRBKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080187575-A1 Pyrimidine Derivatives VICHEM CHEMIE KFT (HU) 2008-08-07 US claimed
EP-1786781-A2 PYRIMIDINE DERIVATIVES GPC Biotech AG (DE) 2007-05-23 EP claimed
WO-2006021458-A2 PYRIMIDINE DERIVATIVES GPC BIOTECH AG (DE) 2006-03-02 WO claimed
US-20080187575-A1 Pyrimidine Derivatives VICHEM CHEMIE KFT (HU) 2008-08-07 US disclosed
EP-1786781-A2 PYRIMIDINE DERIVATIVES GPC Biotech AG (DE) 2007-05-23 EP disclosed
WO-2006021458-A2 PYRIMIDINE DERIVATIVES GPC BIOTECH AG (DE) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080187575-A1 Pyrimidine Derivatives TYMP, TDP1, PNP PDGFRA 373/4885ABL1 2843/4885BCR 2315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.